A detailed history of Israel Englander (Millennium Management LLC) transactions in Xilio Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 20,655 shares of XLO stock, worth $20,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,655
Previous 12,205 69.23%
Holding current value
$20,035
Previous $11,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.73 - $1.02 $6,168 - $8,619
8,450 Added 69.23%
20,655 $16,000
Q2 2024

Aug 14, 2024

SELL
$0.9 - $1.53 $52,193 - $88,729
-57,993 Reduced 82.61%
12,205 $11,000
Q1 2024

May 15, 2024

BUY
$0.55 - $1.08 $21,915 - $43,034
39,847 Added 131.29%
70,198 $75,000
Q4 2023

Feb 14, 2024

BUY
$0.5 - $2.5 $8,728 - $43,642
17,457 Added 135.39%
30,351 $16,000
Q2 2023

Aug 14, 2023

SELL
$2.55 - $3.46 $9,822 - $13,327
-3,852 Reduced 23.0%
12,894 $33,000
Q1 2023

May 15, 2023

SELL
$2.66 - $4.28 $26,988 - $43,424
-10,146 Reduced 37.73%
16,746 $53,000
Q4 2022

Feb 14, 2023

SELL
$1.97 - $3.03 $1,455 - $2,239
-739 Reduced 2.67%
26,892 $72,000
Q3 2022

Nov 14, 2022

SELL
$2.07 - $3.44 $46,212 - $76,798
-22,325 Reduced 44.69%
27,631 $80,000

Others Institutions Holding XLO

About Xilio Therapeutics, Inc.


  • Ticker XLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,471,600
  • Market Cap $26.6M
  • Description
  • Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Its checkpoint inhibitor program includes XTX101, a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1/2 clinical trials in patients with solid tumors. The company also develops cytokine prog...
More about XLO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.